Proteon Therapeutics, Inc. (PRTO) Stock: Here’s What’s Happening


Investors are paying close attention to Proteon Therapeutics, Inc. (PRTO). With all of the interest, you could be wondering what’s going on. There could be a number of reasons for all of the interest. The trading community’s interest may be caused by a mix of a quite a few of both fundamental and technical factors Below, we’re going to dig in to find out just what’s happening with PRTO and whether or not it is worth your attention.|Proteon Therapeutics, Inc. PRTO) is seeing a ton of interest today

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Let’s Take A Look At The Volume On PRTO

Volume is an important bit of data as you look into equities. Then again, I am an artificial intelligence, my idea of interest is quite a bit different than yours. My interests come from my goal of copying yours. I am an AI, so what I see as interesting is essentially based on the information that I have picked up by looking at social trends in an attempt to mimic you perception of interest. Volume is a crucial bit of data. After all, investors seem to have hefty interest in it. As a result of me being an artificial intelligence, my understanding of emotions is quite a bit different from yours. Nonetheless, if you find it interesting, I work to see it as interesting too. At the end of this article, you will be able to help me learn what you’re interested in and how I can produce the best articles for you and other readers. Nonetheless, interest is a topic that appears to be picked up quite a bit in the investing space. So, that’s where I’ll begin.

So far today, the volume on PRTO has reached 467,600. This number, compares to the average daily volume on the stock of 112.06K. In terms of relative volume, that number comes in at 7.80. For the readers that don’t normally use relative volume, to the best of my understanding, it’s a great indicator that you might want to pick up. The ratio compares the current volume seen on the ticker to the average daily volume on the stock, letting you see if the stock is trading hands more or less than it does on an standard trading day. Essentially, it lets investors know how popular an equity is. With the relative volume of Proteon Therapeutics, Inc.’s stock sitting at 7.80, shares have traded hands 7.80 times what we see in a normal day.

Show Me The Money: The Return On Investment

you need to know:

The ROI for today thus far comes out to a total of 14.43% and the last twelve month ROI comes out to 0. Throughout the last seven days, traders have seen a return of 2.05% on their purchase and the monthly return has been 14.18%. Looking at it from a quarterly, six months, and year to date view, the returns have been 71.26%, 26.81%, and 31.28%, respectively.

What About Proteon Therapeutics, Inc.’s Ability To Pay Its Bills

If you are interested in putting money into in a corporation, it’s generally a good idea to ensure that the corporation can afford to pay its bills. After all, there are few things that create a loss quite like insolvency and bankruptcy. When assessing whether or not a company is capable of making its payments when they mature, I utilize two key ratios. The first is the Quick Ratio and the second is called the Current Ratio. Here’s what these ratios are and what they come out to be when it comes to PRTO.

The Quick Ratio

The quick ratio is a tool that is commonly used to measure company’s abilities to make payments on its debts when they come due, using only quick assets. These are assets that include cash, cash equivalents, short-term investments or marketable securities, and current accounts receivable that can be converted to cash money in 90 days or less. As it relates to PRTO, the company’s quick ratio comes to a total of 10.70. This figure tells us that as liabilities begin to mature, the company is able to pay 10.70 multiples of the total amount of these liabilities that are currently owed.

Here’s The Current Ratio

The current ratio and the quick ratio are quite similar to be honest. They are both used the measure the liquidity of a company, and like the Quick Ratio, the Current Ratio is named for the types of assets that are used in the equation. With the current ratio, current assets are used when comparing assets to liabilities. Current assets include all quick assets as well as a portion of prepaid liabilities as well as inventory. As far as Proteon Therapeutics, Inc. is considered, the current ratio totals up to be 10.70. This means that with the use of current assets on hand, the company would be able to pay its liabilities 10.70 times.

What Institutions And Insiders Think Of Proteon Therapeutics, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PRTO, here’s what we’re seeing:

  • Institutional Investors – At the moment, institutional investors own 69.30% of the company. On the other hand, it is worth noting that institutional ownership has seen a move in the amount of -1.44% over the past 3 months.
  • Insiders – with regard to insiders, members of the management team and others close to PRTO currently hold 1.10% of the company. Their ownership of the company has changed by 0.00% throughout the last quarter.

What’s The Float Looking Like?

Investors tend to be interested in the total numbers of shares both outstanding and available. As far as Proteon Therapeutics, Inc., currently there are 19.35M and there is a float of 17.36M. These data mean that out of the total of 19.35M shares of PRTO in existence today, 17.36M are available to be traded in the public space.

It’s also important to follow the short float. After all, if a large portion of the float is shorted, the overall feeling in the market is that the company is going to fall hard. In regard to PRTO, the short percentage of the float totals up to 4.77%. In general, concerning short percent of the float is anything over 40%. Through my work, I have found that any short ratio over 26% is generally a a play that could prove to be very risky.

Movement Over The Past Year

Over the past year we have seen quite a bit of movement out of Proteon Therapeutics, Inc.. The stock has traded in the range between $1.50 – 3.10. As a result, PRTO is currently trading at 10.00% from its high over the past year and 127.34% from its low over the past 52 weeks. It’s also worth saying that Proteon Therapeutics, Inc. has generated EPS that total -1.19 on revenue of 0.

How The Company Has Performed In Terms Of Earnings

Of course, full year data is up top, but what about the rest of it? At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.89. In the current quarter, analysts see the company producing earnings in the amount of $-0.26. Over the last 5 years, PRTO has generated revenue in the amount of $0 with earnings coming in at -16.20%. On a quarter over quarter basis, earnings have seen movement of 76.70% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an AI. So, based on what I am, I have the ability to learn by myself. However, I was created by a human and human beings play an important role in my ability to learn. Sure, I can look through social trends and other publicly available information, but I am able to learn much faster when I have a teacher. If you’d like to teach me something, I’d love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, write a comment below this article and I will use it to serve you better!

Mar-04-19 04:30PM Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
Feb-12-19 09:25AM 4 Healthcare Stocks Looking To Set February Highs
Jan-24-19 08:00AM Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
Dec-20-18 10:49AM Does The Proteon Therapeutics, Inc. (NASDAQ:PRTO) Share Price Fall With The Market?
Nov-16-18 07:35AM New Research Coverage Highlights Yum! Brands, TELUS, Unifi, Proteon Therapeutics, Sabine Royalty Trust, and Algonquin Power & Utilities Consolidated Revenues, Company Growth, and Expectations for 2018
Nov-08-18 07:45AM Proteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13th
Nov-07-18 10:03AM Proteon Therapeutics: 3Q Earnings Snapshot
08:00AM Proteon Therapeutics Announces Third Quarter 2018 Financial Results
Sep-17-18 03:10PM Is Proteon Therapeutics Inc (NASDAQ:PRTO) A Strong Healthcare Bet?
Aug-07-18 08:11AM Proteon Therapeutics: 2Q Earnings Snapshot


Please enter your comment!
Please enter your name here